IDO1 and cancer: ICD is of great interest in cancer immunotherapy, as it can enhance the effectiveness of immune checkpoint inhibitors, such as IDO1 inhibitors, by priming the immune system to recognize and attack cancer cells (Bonaventura et al., 2019; Feng et al., 2020).